Tetra Radar · FDA Approvals · Decision date
MoonLake Immunotherapeutics: FDA decision date
MoonLake Immunotherapeutics (MLTX) · December 2026
HS: . ◦ Expected to receive decision on BLA acceptance by the end of November 2026 and a Prescription Drug User Fee Act (PDUFA) date allocation and decision on Priority Review by mid December 2026 . ◦ Expected mid-cycle review in H1 2027 . ◦ Expected to conclude VELA-TEEN clinical trial in Q4 2026 and present final topline results at a scientific meeting in…
Source: 8-K of 4 November 2026
The decision is pending.
MoonLake Immunotherapeutics on Tetra Radar
A PDUFA date is the date by which the FDA has said it will decide on an application. Dates can move, and a decision is not an approval. Tetra Radar observes public information for research purposes. It does not provide investment advice.